For the quarter ending 2025-09-30, ENZN had -$1,038K decrease in cash & cash equivalents over the period.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net (loss) income | -824 | -1,514 |
| Deferred income taxes | 16 | -25 |
| Changes in operating assets and liabilities | 230 | -249 |
| Net cash (used in) provided by operating activities | -1,038 | -1,290 |
| Preferred stock dividend payments | 0 | 1,275 |
| Net cash used in financing activities | 0 | -1,275 |
| Net decrease in cash and cash equivalents | -1,038 | -2,565 |
| Cash and cash equivalents at beginning of period | 46,859 | - |
| Cash and cash equivalents at end of period | 43,256 | - |
ENZON PHARMACEUTICALS, INC. (ENZN)
ENZON PHARMACEUTICALS, INC. (ENZN)